Salipro Biotech and Icosagen announce the initiation of a multi-target collaboration for the discovery and characterization of monoclonal antibodies
STOCKHOLM, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Sumitomo Pharma Co., Ltd. to reveal the mechanism of action and pharmacological characterization of a drug candidate.
Salipro Biotech obtains granted patent in Japan, protecting its proprietary Salipro platform technology to enable the development of therapeutics against challenging drug targets, including GPCRs,...
Salipro Biotech and DyNAbind Announce Milestone Achievement in Collaboration to Enable DEL for Membrane Proteins
Salipro Biotech announced on Nov. 8, 2022 that it has entered into a research collaboration and license agreement with Sanofi on the discovery of therapeutic biologics against a challenging drug target.
Swedish biotech company Salipro Biotech AB announced that it has entered into a research collaboration and license agreement with Sanofi on the discovery of therapeutic biologics against a challenging drug target.
STOCKHOLM, Nov. 8, 2022 /PRNewswire/ -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration and license agreement with Sanofi on the discovery of therapeutic biologics against a challenging drug target.